PAUL BISARO Insider Trading Transactions
Get free email notifications about insider trading for PAUL BISARO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL BISARO. PAUL BISARO is in BARR PHARMACEUTICALS INC ($BRL) and President & COO in BARR PHARMACEUTICALS INC ($BRL) and Director in TherapeuticsMD, Inc. ($TXMD) and President and CEO in IMPAX LABORATORIES INC ($IPXL) and Director in ZIMMER BIOMET HOLDINGS, INC. ($ZBH) and Director in Zoetis Inc. ($ZTS) and Director in Allergan plc ($AGN) and Exec Chairman in Allergan plc ($AGN) and Director in Amneal Pharmaceuticals, Inc. ($AMRX) and Executive Chairman in Amneal Pharmaceuticals, Inc. ($AMRX).
Latest Insider Trading Transactions of PAUL BISARO
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGN, AMRX, BRL, IPXL, TXMD, ZBH, ZTS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2021 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | M | 0.00 | 2,779 | 0 | 5,695 | |
Feb 17 2021 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Buy | M | 0.00 | 2,779 | 0 | 14,527 | 11.7 K to 14.5 K (+23.66 %) |
Feb 12 2021 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | A | 0.00 | 1,431 | 0 | 8,474 | |
Jun 19 2020 | TXMD | TherapeuticsMD, In ... | BISARO PAUL | Director | Option Exercise | A | 0.00 | 96,864 | 0 | 96,864 | |
Jun 08 2020 | TXMD | TherapeuticsMD, In ... | BISARO PAUL | Director | Buy | P | 1.14 | 50,000 | 57,000 | 50,000 | 0 to 50 K |
Feb 19 2020 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | M | 0.00 | 3,705 | 0 | 7,003 | |
Feb 19 2020 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Buy | M | 0.00 | 3,704 | 0 | 11,748 | 8 K to 11.7 K (+46.05 %) |
Feb 13 2020 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | A | 0.00 | 1,596 | 0 | 10,708 | |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Executive Chairman | Option Exercise | M | 0.00 | 24,983 | 0 | 74,950 | |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Executive Chairman | Payment of Exercise | F | 13.44 | 12,529 | 168,390 | 29,454 | 42 K to 29.5 K (-29.84 %) |
May 09 2019 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Executive Chairman | Buy | M | 0.00 | 24,983 | 0 | 41,983 | 17 K to 42 K (+146.96 %) |
Mar 12 2019 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Executive Chairman | Buy | P | 11.97 | 17,000 | 203,490 | 17,000 | 0 to 17 K |
Feb 21 2019 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | M | 0.00 | 4,150 | 0 | 9,058 | |
Feb 21 2019 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Buy | M | 0.00 | 4,150 | 0 | 8,044 | 3.9 K to 8 K (+106.57 %) |
Feb 14 2019 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | A | 0.00 | 2,628 | 0 | 13,209 | |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Director | Option Exercise | A | 0.00 | 99,933 | 0 | 99,933 | |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Director | Option Exercise | A | 15.01 | 408,719 | 6,134,872 | 408,719 | |
May 08 2018 | AMRX | Amneal Pharmaceuti ... | BISARO PAUL | Director | Option Exercise | A | 12.70 | 850,000 | 10,795,000 | 850,000 | |
May 08 2018 | IPXL | Impax Laboratories ... | BISARO PAUL | President and CEO | Option Exercise | D | 12.70 | 850,000 | 10,795,000 | 0 | |
May 04 2018 | AGN | Allergan plc | BISARO PAUL | Director | Grant | A | 151.07 | 1,985 | 299,874 | 263,729 | 261.7 K to 263.7 K (+0.76 %) |
May 03 2018 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | M | 0.00 | 3,895 | 0 | 10,530 | |
May 03 2018 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Buy | M | 0.00 | 3,894 | 0 | 3,894 | 0 to 3.9 K |
May 03 2018 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 152.94 | 588 | 89,929 | 261,744 | 262.3 K to 261.7 K (-0.22 %) |
Mar 06 2018 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 148.73 | 2,921 | 434,440 | 262,332 | 265.3 K to 262.3 K (-1.10 %) |
Feb 15 2018 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | A | 0.00 | 2,730 | 0 | 14,403 | |
Jan 02 2018 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 163.58 | 6,521 | 1,066,705 | 265,253 | 271.8 K to 265.3 K (-2.40 %) |
Oct 30 2017 | AGN | Allergan plc | BISARO PAUL | Director | Option Exercise | M | 0.00 | 37,727 | 0 | 0 | |
Oct 30 2017 | AGN | Allergan plc | BISARO PAUL | Director | Buy | M | 0.00 | 37,727 | 0 | 271,774 | 234 K to 271.8 K (+16.12 %) |
May 05 2017 | AGN | Allergan plc | BISARO PAUL | Director | Grant | A | 245.25 | 1,223 | 299,941 | 234,047 | 232.8 K to 234 K (+0.53 %) |
May 05 2017 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 243.76 | 214 | 52,165 | 232,824 | 233 K to 232.8 K (-0.09 %) |
Apr 04 2017 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 121.49 | 98 | 11,906 | 3,095 | |
Mar 29 2017 | IPXL | IMPAX LABORATORIES ... | BISARO PAUL | President and CEO | Option Exercise | A | 12.70 | 850,000 | 10,795,000 | 850,000 | |
Mar 07 2017 | AGN | Allergan plc | BISARO PAUL | Director | Payment of Exercise | F | 245.63 | 2,862 | 702,993 | 233,038 | 235.9 K to 233 K (-1.21 %) |
Mar 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Sell | S | 248.40 | 2,371 | 588,956 | 235,900 | 238.3 K to 235.9 K (-1.00 %) |
Mar 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Sell | S | 247.63 | 27,688 | 6,856,379 | 238,271 | 266 K to 238.3 K (-10.41 %) |
Mar 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Sell | S | 246.64 | 8,267 | 2,038,973 | 265,959 | 274.2 K to 266 K (-3.01 %) |
Mar 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Sell | S | 245.73 | 31,674 | 7,783,252 | 274,226 | 305.9 K to 274.2 K (-10.35 %) |
Feb 16 2017 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | A | 0.00 | 3,635 | 0 | 11,594 | |
Feb 06 2017 | AGN | Allergan plc | BISARO PAUL | Director | Grant | A | 229.52 | 444 | 101,907 | 305,900 | 305.5 K to 305.9 K (+0.15 %) |
Feb 03 2017 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Option Exercise | C | 229.32 | 7,105 | 1,629,319 | 0 | |
Feb 03 2017 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Payment of Exercise | F | 229.32 | 3,411 | 782,211 | 185,456 | 188.9 K to 185.5 K (-1.81 %) |
Feb 03 2017 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Grant | A | 229.32 | 7,105 | 1,629,319 | 188,867 | 181.8 K to 188.9 K (+3.91 %) |
Jan 04 2017 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 103.39 | 115 | 11,890 | 2,992 | |
Oct 04 2016 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 129.37 | 92 | 11,902 | 2,871 | |
Jul 01 2016 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 119.53 | 99 | 11,833 | 2,775 | |
May 05 2016 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 0.00 | 1,128 | 0 | 3,515 | |
May 05 2016 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 115.24 | 500 | 57,620 | 2,675 | |
Apr 04 2016 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 106.74 | 111 | 11,848 | 2,171 | |
Feb 22 2016 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | A | 0.00 | 4,064 | 0 | 7,896 | |
Jan 05 2016 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 102.40 | 116 | 11,878 | 2,055 | |
Dec 30 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Gift | G | 0.00 | 120,000 | 0 | 120,000 | 240 K to 120 K (-50.00 %) |
Oct 02 2015 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 94.02 | 126 | 11,847 | 1,935 | |
Aug 24 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Buy | P | 297.42 | 1,000 | 297,422 | 421,755 | 420.8 K to 421.8 K (+0.24 %) |
Jul 01 2015 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 109.83 | 108 | 11,862 | 1,805 | |
May 07 2015 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 0.00 | 1,180 | 0 | 2,387 | |
May 07 2015 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 110.21 | 500 | 55,105 | 1,697 | |
May 01 2015 | ZTS | Zoetis Inc. | BISARO PAUL | Director | Option Exercise | A | 0.00 | 3,811 | 0 | 3,811 | |
Apr 02 2015 | ZBH | ZIMMER BIOMET HOLD ... | BISARO PAUL | Director | Option Exercise | A | 117.67 | 101 | 11,885 | 1,195 | |
Mar 09 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Payment of Exercise | F | 295.70 | 1,776 | 525,163 | 420,755 | 422.5 K to 420.8 K (-0.42 %) |
Mar 09 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Grant | A | 0.00 | 13,702 | 0 | 422,531 | 408.8 K to 422.5 K (+3.35 %) |
Mar 09 2015 | AGN | Allergan plc | BISARO PAUL | Exec Chairman | Payment of Exercise | F | 295.70 | 1,316 | 389,141 | 408,829 | 410.1 K to 408.8 K (-0.32 %) |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 16,321 | 433,812 | 0 | ||
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 15,000 | 398,700 | 16,321 | ||
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | M | 54.76 | 1 | 55 | 133,077 | 133.1 K to 133.1 K (0.00 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | M | 54.74 | 7,020 | 384,302 | 133,078 | 140.1 K to 133.1 K (-5.01 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | M | 54.49 | 9,300 | 506,740 | 140,098 | 149.4 K to 140.1 K (-6.22 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 16,321 | 433,812 | 149,398 | 133.1 K to 149.4 K (+12.26 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.31 | 5,000 | 271,551 | 133,077 | 138.1 K to 133.1 K (-3.62 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 53.95 | 10,000 | 539,500 | 138,077 | 148.1 K to 138.1 K (-6.75 %) | |
Oct 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 15,000 | 398,700 | 148,077 | 133.1 K to 148.1 K (+11.27 %) | |
Oct 22 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 31,320 | ||
Oct 22 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.28 | 10,000 | 542,800 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 22 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 19 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 41,320 | ||
Oct 19 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.70 | 10,000 | 547,047 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 19 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 5,400 | 143,532 | 51,320 | ||
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 56,720 | ||
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.46 | 5,400 | 299,494 | 133,077 | 138.5 K to 133.1 K (-3.90 %) | |
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 5,400 | 143,532 | 138,477 | 133.1 K to 138.5 K (+4.06 %) | |
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.21 | 10,000 | 552,079 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 18 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 66,720 | ||
Oct 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.75 | 10,000 | 557,525 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 11 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 86,720 | ||
Oct 11 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.61 | 10,000 | 556,120 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 11 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 26.58 | 10,000 | 265,800 | 86,720 | ||
Oct 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.78 | 10,000 | 557,834 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Oct 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 26.58 | 10,000 | 265,800 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Oct 09 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 7,196 | 261,407 | 25,000 | ||
Oct 09 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 56.00 | 7,196 | 402,976 | 133,077 | 140.3 K to 133.1 K (-5.13 %) | |
Oct 09 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 7,196 | 261,407 | 140,273 | 133.1 K to 140.3 K (+5.41 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 3,800 | 138,041 | 32,196 | ||
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 56,503 | 2,052,568 | 35,996 | ||
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 57.11 | 3,800 | 217,035 | 133,077 | 136.9 K to 133.1 K (-2.78 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 3,800 | 138,041 | 136,877 | 133.1 K to 136.9 K (+2.86 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 56.92 | 2,727 | 155,230 | 133,077 | 135.8 K to 133.1 K (-2.01 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 57.50 | 11,503 | 661,423 | 135,804 | 147.3 K to 135.8 K (-7.81 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 56.89 | 42,273 | 2,404,848 | 147,307 | 189.6 K to 147.3 K (-22.30 %) | |
Oct 03 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 56,503 | 2,052,568 | 189,580 | 133.1 K to 189.6 K (+42.46 %) | |
Oct 01 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 20,000 | 726,534 | 92,499 | ||
Oct 01 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 56.08 | 20,000 | 1,121,600 | 133,077 | 153.1 K to 133.1 K (-13.07 %) | |
Oct 01 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 20,000 | 726,534 | 153,077 | 133.1 K to 153.1 K (+15.03 %) | |
Sep 27 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 36.33 | 25,000 | 908,168 | 112,499 | ||
Sep 27 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 55.86 | 25,000 | 1,396,473 | 133,077 | 158.1 K to 133.1 K (-15.82 %) | |
Sep 27 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 36.33 | 25,000 | 908,168 | 158,077 | 133.1 K to 158.1 K (+18.79 %) | |
Sep 25 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 45,000 | 1,105,502 | 0 | ||
Sep 25 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.26 | 25,000 | 1,356,500 | 133,077 | 158.1 K to 133.1 K (-15.82 %) | |
Sep 25 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.25 | 20,000 | 1,085,050 | 158,077 | 178.1 K to 158.1 K (-11.23 %) | |
Sep 25 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 45,000 | 1,105,502 | 178,077 | 133.1 K to 178.1 K (+33.82 %) | |
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 10,000 | 245,667 | 45,000 | ||
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 10,000 | 245,667 | 55,000 | ||
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 54.00 | 10,000 | 540,000 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 10,000 | 245,667 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 53.13 | 10,000 | 531,250 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Sep 24 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 10,000 | 245,667 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Sep 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 10,000 | 245,667 | 65,000 | ||
Sep 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 53.10 | 10,000 | 530,979 | 133,077 | 143.1 K to 133.1 K (-6.99 %) | |
Sep 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 10,000 | 245,667 | 143,077 | 133.1 K to 143.1 K (+7.51 %) | |
Sep 13 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 5,000 | 122,834 | 80,000 | ||
Sep 13 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 52.00 | 5,000 | 260,002 | 133,077 | 138.1 K to 133.1 K (-3.62 %) | |
Sep 13 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 5,000 | 122,834 | 138,077 | 133.1 K to 138.1 K (+3.76 %) | |
Sep 17 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Option Exercise | M | 24.57 | 5,000 | 122,834 | 75,000 | ||
Sep 17 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Sell | S | 51.24 | 5,000 | 256,218 | 133,077 | 138.1 K to 133.1 K (-3.62 %) | |
Sep 17 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | Buy | M | 24.57 | 5,000 | 122,834 | 138,077 | 133.1 K to 138.1 K (+3.76 %) | |
Sep 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 24.57 | 5,000 | 122,834 | 85,000 | |
Sep 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Sell | S | 52.00 | 5,000 | 260,000 | 133,077 | 138.1 K to 133.1 K (-3.62 %) |
Sep 12 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | M | 24.57 | 5,000 | 122,834 | 138,077 | 133.1 K to 138.1 K (+3.76 %) |
Aug 14 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 35.01 | 2,856 | 99,989 | 0 | |
Aug 14 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 43.34 | 2,310 | 100,115 | 0 | |
Aug 14 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 26.58 | 11,277 | 299,743 | 0 | |
Aug 14 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | M | 35.01 | 2,856 | 99,989 | 133,078 | 130.2 K to 133.1 K (+2.19 %) |
Aug 14 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | M | 43.34 | 2,310 | 100,115 | 130,222 | 127.9 K to 130.2 K (+1.81 %) |
Aug 14 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | M | 26.58 | 11,277 | 299,743 | 127,912 | 116.6 K to 127.9 K (+9.67 %) |
Aug 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 11.06 | 12,377 | 136,890 | 0 | |
Aug 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 11.06 | 25,100 | 277,606 | 12,377 | |
Aug 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Sell | S | 55.45 | 25,100 | 1,391,690 | 116,635 | 141.7 K to 116.6 K (-17.71 %) |
Aug 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Sell | S | 55.56 | 12,377 | 687,670 | 141,735 | 154.1 K to 141.7 K (-8.03 %) |
Aug 10 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | M | 11.06 | 37,477 | 414,496 | 154,112 | 116.6 K to 154.1 K (+32.13 %) |
Jun 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 11.06 | 20,000 | 221,200 | 37,477 | |
Jun 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Sell | S | 52.14 | 10,000 | 521,449 | 116,139 | 126.1 K to 116.1 K (-7.93 %) |
Jun 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Sell | S | 52.06 | 10,000 | 520,619 | 126,139 | 136.1 K to 126.1 K (-7.35 %) |
Jun 20 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | M | 11.06 | 20,000 | 221,200 | 136,139 | 116.1 K to 136.1 K (+17.22 %) |
Jun 08 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 11.06 | 10,000 | 110,600 | 57,477 | |
Jun 08 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 10.05 | 9,949 | 99,955 | 0 | |
Jun 08 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Option Exercise | M | 11.06 | 19 | 210 | 0 | |
Jun 08 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Sell | S | 52.29 | 10,000 | 522,929 | 116,139 | 126.1 K to 116.1 K (-7.93 %) |
Jun 08 2007 | BRL | BARR PHARMACEUTICA ... | BISARO PAUL | President & COO | Buy | M | 10.05 | 9,949 | 99,955 | 126,139 | 116.2 K to 126.1 K (+8.56 %) |